Transpire Bio
Bill Schachtner has a strong background in pharmaceutical development and project management, with a focus on inhalation products. With experience in companies like Lupin, PPD, and 3M Drug Delivery Systems, Bill has held various roles such as Director, President, and Research Scientist. Currently serving as the Chief Technical Operations Officer at Transpire Bio, their expertise lies in overseeing development and manufacturing activities, ensuring projects are completed efficiently and effectively.
Transpire Bio
We are a team of dedicated professionals with expertise in delivering medicines to the body through the inhaled route. The Leadership Team combined has over 100 years of experience in developing inhaled medicines and bringing these medicines to the U.S. and European markets. Our purpose at Transpire Bio is framed by two core elements: Access and Innovation. For common diseases where adequate therapies exist, we seek to expand access to these complex inhaled medicines globally by developing and commercializing lower-cost generic alternatives. For diseases with few treatment options, we seek to innovate by harnessing existing known mechanisms of action, and dramatically improve the risk-benefit profile of selected molecules by developing these as inhaled therapeutics. Our understanding of the complexities of inhaled drug-device products will allow us to advance these therapies and improve the health of people around the globe.